Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1051-1059

  Bae, Eun Hui ^a   Kim, In Jin ^a   Park, Jeong Woo ^a   Ma, Seong Kwon ^a   Lee, Jong Un ^a   Kim, Soo Wan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

DOCA salt; Glomerulosclerosis; Hypertension; Rosuvastatin

Indexed keywords

ALBUMIN; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; DEOXYCORTICOSTERONE ACETATE; ED 1 PROTEIN; ENDOTHELIN 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; ROSUVASTATIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; DIET; DRUG EFFECT; EXCRETION; FIBROSIS; GLOMERULOSCLEROSIS; HYPERTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; MINERALOCORTICOID HYPERTENSION; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; STAINING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TUBULOINTERSTITIAL FIBROSIS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOTTING, WESTERN; DESOXYCORTICOSTERONE; GLOMERULONEPHRITIS; HYPERTENSION; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MALE; MINERALOCORTICOIDS; NEPHRITIS, INTERSTITIAL; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM CHLORIDE, DIETARY; THIAZOLIDINEDIONES;

EID: 77950291523     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp604     Document Type: Article

References (40)

1. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666
2. Lee TM, Su SF, Tsai CH. Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension 2002; 40: 67-73
3. Verma A, Ranganna KM, Reddy RS, et al. Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease. Am J Cardiol 2005; 96: 1290-1292
4. McTaggart F, Buckett L, Davidson R, et al. Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor. Am J Cardiol 2001; 87: 28B-32B
5. Moriyama T, Kawada N, Nagatoya K, et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney int 2001; 59: 2095-2103
6. Joyce M, Kelly C, Winter D, et al. Pravastatin, a 3-hydroxy-3-methyl- glutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion. J Surg Res 2001; 101: 79-84
7. Gavras H, Brunner HR, Laragh JH, et al. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res 1975; 36: 300-309
8. Iglarz M, Touyz RM, Viel EC, et al. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angio-tensin system. Am J Hypertens 2004; 17: 597-603
9. Sun Y, Zhang J, Lu L, et al. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 2002; 161: 1773-1781
10. Lijnen PJ, Petrov VV, Fagard RH. Association between transforming growth factor-beta and hypertension. Am J Hypertens 2003; 16: 604-611
11. Hartner A, Klanke B, Cordasic N, et al. Statin treatment reduces glo-merular inflammation and podocyte damage in rat deoxycorticoster-one- acetate-salt hypertension. J Hypertens 2009; 27: 376-385
12. Gadola L, Noboa O, Marquez MN, et al. Calcium citrate ameliorates the progression of chronic renal injury. Kidney Int 2004; 65: 1224-1230
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-408
14. Kim SW, Schou UK, Peters CD, et al. Increased apical targeting of renal epithelial sodium channel subunits and decreased expression of type 2 11beta-hydroxysteroid dehydrogenase in rats with CCl4-in-duced decompensated liver cirrhosis. J Am Soc Nephrol 2005; 16: 3196-3210
15. Glorioso N, Troffa C, Filigheddu F, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 1999; 34: 1281-1286
16. Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension 1997; 30: 968-974
17. Gross V, Schneider W, Schunck WH, et al. Chronic effects of lovastat-in and bezafibrate on cortical and medullary hemodynamics in deox-ycorticosterone acetate-salt hypertensive mice. J Am Soc Nephrol 1999; 10: 1430-1439
18. Klahr S, Schreiner G, Ichigawa I. The progression of renal disease. N Engl J Med 1998; 318: 1657-1666
19. Elmarakby AA, Quigley JE, Imig JD, et al. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Reg-ul Integr Comp Physiol 2008; 294: R76-R83
20. Sironi L, Gianazza E, Gelosa P, et al. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflamma-tory effects. Arterioscler Thromb Vasc Biol 2005; 25: 598-603
21. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol 2005; 43: 19-29
22. Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvasta-tin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998; 101: 2711-2719
23. Lee TM, Lin MS, Chou TF, et al. Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005; 289: H220-H227
24. Laufs U, Kilter H, Konkol C, et al. Impact of HMG-CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 2002; 53: 911-920
25. Delerive P, Martin-Nizard F, Chinetti G, et al. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 1999; 85: 394-402
26. Satoh H, Tsukamoto K, Hashimoto Y, et al. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARγ on vascular endothelial function. Bio-chem Biophys Res Commun 1999; 254: 757-763
27. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
28. Sakamoto H, Sasaki S, Hirata Y, et al. Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 1990; 169: 462-468
29. Zoja C, Orisio S, Perico N, et al. Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-beta, thrombin, and a thromboxane A2 analogue. Lab Invest 1991; 64: 16-20
30. Kohan DE. Endothelin synthesis by rabbit renal tubule cells. Am J Physiol 1991; 261: F221-F226
31. Kohan DE. Production of endothelin-1 by rat mesangial cells: regulation by tumor necrosis factor. J Lab Clin Med 1992; 119: 477-484
32. Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and in-terleukin-6 inhibition attenuate the proatherogenic effects of C-reac-tive protein. Circulation 2002; 105: 1890-1896
33. Murphy M, Crean J, Brazil DP, et al. Regulation and consequences of differential gene expression in diabetic kidney disease. Biochem Soc Trans 2008; 36: 941-945
34. Kagami S, Border WA, Miller DE, et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437
35. Okada H, Kikuta T, Kobayashi T, et al. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibro-genesis. J Am Soc Nephrol 2005; 16: 133-143
36. Dahly AJ, Hoagland KM, Flasch AK, et al. Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: R757-R767
37. Matsuda H, Fukuda N, Ueno T, et al. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. J Am Soc Nephrol 2006; 17: 422-432
38. Eddy AA. Interstitial nephritis induced by protein-overloaded pro-teinuria. Am J Pathol 1989; 135: 719-733
39. Hutchison FN, Kaysen GA. Albuminuria causes lysozymuria in rats with Heymann nephritis. Kidney Int 1988; 33: 787-791
40. Valentin JP, Sechi LA, Griffin CA, et al. Gene expression of the renin-angiotensin system in compensatory renal hypertrophy secondary to contralateral nephrectomy. Arch Mal Coeur Vaiss 1994; 87: 1115-1117